New Strategies for Diagnosing and Classifying MDS in 2012

During this webinar, Mikkael Sekeres, MD, MS and Timothy Graubert, MD will discuss the most important research on the diagnosis and classification of MDS that was presented at the 2011 American Society of Hematology (ASH) annual meeting. The focus will be on helping you understand these new and emerging diagnostic procedures and prognostic models and how these tools might allow doctors to refine and tailor treatments to each specific MDS patient’s needs in the future. In addition, the presenters will discuss findings about the role genetics might play in identifying who might respond best to certain treatments and in the development of new therapies for MDS or related disorders. In summary, the presenters will discuss the how these new procedures and models, along with a better understanding of genetics in MDS, may impact patient care and outcomes in 2012 and beyond.